We could not find any results for:
Make sure your spelling is correct or try broadening your search.
ValiRx PLC 30 October 2024 30 October 2024 ValiRx PLC ("ValiRx" or the "Company") Update on proposed sub-license of VAL201 London, UK - ValiRx Plc (AIM: VAL), a life science company...
ValiRx PLC 18 October 2024 ValiRx plc ("ValiRx" or the "Company") Directorate Change ValiRx plc (AIM: VAL), a life sciences company focusing on early-stage cancer therapeutics and...
ValiRx PLC 14 October 2024 ValiRx plc ("ValiRx" or the "Company") Investor Webinar ValiRx Plc (AIM: VAL), a life science company focusing on early-stage cancer therapeutics and women's...
ValiRx PLC 07 October 2024 ValiRx plc ("ValiRx" or the "Company") Inaphaea Co-Marketing Agreement London, UK - ValiRx Plc (AIM: VAL), a life science company focusing on early-stage...
The following is a round-up of earnings for London-listed companies, issued on Friday and not separately reported by ...
ValiRx PLC 27 September 2024 VALIRX PLC ("ValiRx", "the Company" or "the Group") HALF YEARLY REPORT FOR THE PERIOD ENDED 30 JUNE 2024 London, UK., 2024: ValiRx Plc (AIM: VAL), a life...
ValiRx PLC 26 September 2024 26 September 2024 ValiRx PLC ("ValiRx" or the "Company") Conclusion of Evaluation Project London, UK - ValiRx Plc (AIM: VAL), a life science company...
ValiRx PLC 24 September 2024 ValiRx plc ("ValiRx" or the "Company") Inaphaea Co-Marketing Agreement London, UK - ValiRx Plc (AIM: VAL), a life science company focusing on early-stage...
ValiRx PLC 18 September 2024 ValiRx plc ("ValiRx" or the "Company") Inaphaea Evaluation and Commercial Use Agreement London, UK - ValiRx Plc (AIM: VAL), a life science company focusing...
ValiRx PLC 16 September 2024 ValiRx plc ("ValiRx" or the "Company") Inaphaea Co-Marketing Agreement London, UK - ValiRx Plc (AIM: VAL), a life science company focusing on early-stage...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.175 | -10.2941176471 | 1.7 | 1.7 | 1.525 | 104275 | 1.53333744 | DE |
4 | 0.275 | 22 | 1.25 | 2.3 | 1.25 | 1400724 | 1.91305406 | DE |
12 | -0.875 | -36.4583333333 | 2.4 | 2.45 | 1.225 | 899020 | 1.8482861 | DE |
26 | -1.525 | -50 | 3.05 | 4.35 | 1.225 | 1239206 | 2.63489654 | DE |
52 | -10.6 | -87.4226804124 | 12.125 | 13.125 | 1.225 | 1029355 | 3.72836577 | DE |
156 | -32.725 | -95.5474452555 | 34.25 | 44.25 | 1.225 | 872178 | 11.11411294 | DE |
260 | -3.675 | -70.6730769231 | 5.2 | 67.5 | 1.225 | 3145576 | 9.62908868 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions